HealthEquity delivered a record third quarter for fiscal 2026, with net income of $52 million, 20% growth in Adjusted EBITDA, and 29% growth in non-GAAP net income per share, reflecting the team's focus on helping members better save, spend and invest for health. The company reported a 7% increase in total revenue to $322.2 million and a substantial rise in net income per diluted share to $0.59 from $0.06 a year ago.
Revenue increased 7% to $322.2 million compared to the same period last year.
Net income per diluted share rose significantly to $0.59, up from $0.06 in the prior year.
Total HSA Assets grew 15% year-over-year, reaching $34.4 billion.
The company returned $93.7 million to shareholders through stock repurchases and further reduced HSA cash repricing risk with a $2.25 billion Treasury bond hedge.
For the fiscal year ending January 31, 2026, HealthEquity management expects revenues between $1.302 billion and $1.312 billion, net income between $197 million and $205 million, and Adjusted EBITDA between $555 million and $565 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance